TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, Our lead product candidate, envafolimab, is a PD-L1 antibody that is being developed for the treatment of sarcoma.

  4350 La Jolla Village Drive, Suite 800 San Diego, CA 92122

 (858) 550-0780

 (858) 550-0786

  info@traconpharma.com